Lannett Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 Million, Earnings Per Share between $0.12 and $0.14
Company to Report Full Financial Results, Host Conference Call on Wednesday, May 8
PHILADELPHIA--(BUSINESS WIRE)-- Lannett Company, Inc. (NYSE MKT: LCI) today announced that it expects to report fiscal 2013 third quarter net sales of approximately $39 million and diluted earnings per share between $0.12 and $0.14. For the prior year third quarter, net sales were $30.7 million and diluted earnings per share were $0.06. The company said the improved performance was driven by strong sales of existing and new products, as well as solid gross margin due to favorable product mix and enhanced manufacturing efficiencies.
Lannett will report full financial results for its fiscal 2013 third quarter Wednesday, May 8, 2013 after the market closes and will host a conference call that same afternoon at 4:30 p.m. Eastern (1:30 p.m. Pacific) to review the company's performance and answer questions.
The conference call will be available to interested parties by dialing 877-261-8992 from the U.S. or Canada, or 847-619-6548 from international locations, passcode 34792521. The call will also be available through a live, listen-only audio broadcast via the Internet at www.lannett.com. Listeners are encouraged to visit the website at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. A playback of the call will be archived and accessible on the same website for at least three months.
About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com.
This news release contains certain statements of a forward-looking nature relating to future events or future business performance.Any such statements, including, but not limited to, the reporting of its preliminary financial results, whether expressed or implied, are subject to risks and uncertainties which can cause actual results to differ materially from those currently anticipated due to a number of factors which include, but are not limited to, the difficulty in predicting the timing or outcome of FDA or other regulatory approvals or actions, the ability to successfully commercialize products upon approval, Lannett's estimated or anticipated future financial results, future inventory levels, future competition or pricing, future levels of operating expenses, product development efforts or performance, and other risk factors discussed in the company's Form 10-K and other documents filed with the Securities and Exchange Commission from time to time.These forward-looking statements represent the company's judgment as of the date of this news release.The company disclaims any intent or obligation to update these forward-looking statements.
Roger Pondel, 310-279-5980
KEYWORDS: United States North America Pennsylvania
The article Lannett Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 Million, Earnings Per Share between $0.12 and $0.14 originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.